Click here if you are having trouble viewing this message.

January newsletter

Agenda Announced
The agenda has been announced for this year's Cell and Gene Therapy Manufacturing Workshop: Practical considerations for commercial realisation. View the agenda and register on our website.

In this newsletter:
- New research shows continued growth in UK cell and gene therapy industry
- Agenda announced for Cell and Gene Therapy Manufacturing Workshop

It has been a great start to 2019 for the cell and gene therapy industry as CGT Catapult data shows a surge in clinical trials. Research highlights the UK's leading position as a development hub and industry confidence in the area. For more insights take a look at the report on UK clinical and pre-clinical trials.

This positivity continued as cell and gene therapies were a hot topic at JP Morgan in San Francisco, and then took centre stage at Phaciliate Leaders World in Miami. To take a look at some of the other events CGT Catapult will be attending in 2019, visit our events page.

An exciting line up of speakers have been announced for this year's Cell and Gene Therapy Manufacturing Workshop, head over to the website to view the agenda and register for this two-day workshop, taking place 11-12 March in central London.

Share this email on social media

News

37% increase in UK clinical trials
New research published by CGT Catapult indicates that the UK pipeline of advanced therapy medicinal products continues to go from strength to strength, with a 37% increase in clinical trials and a 20% increase in preclinical research projects.
Find out more about UK trials

Regulatory webinar: Listen again
In this webinar the team at CGT Catapult discussed how best to go about gaining early regulatory advice and how to engage with regulators globally. The team were joined by Ian Reese, MHRA, for a Q&A.
Listen on demand

Licencing agreement for RALA technology
The collaboration between CGT Catapult and pHion Therapeutics could reduce the cost of cell and gene therapy production by developing a more efficient method of modifying cells.
Read the press release

Events

Agenda confirmed for Cell and Gene Therapy Manufacturing Workshop
The theme for this years workshop is practical considerations for commercial realisation. Join us to learn how to address some of the current issues facing companies manufacturing cell and gene therapies and take a look at the next-generation manufacturing technologies.

Take a look at the agenda.

Confirmed speakers include:

Gene therapy manufacturing
Tim Hillyer, Freeline Therapeutics

Why move to a grade C background?
Seb Hodgkin, Cell Medica

Scheduling materials
Nick Page, Oxford BioMedica

Next generation products
Edward Samuel, Achillies Therapeutics

Automation
Stephen Shapka, Cell and Gene Therapy Catapult

Preparing for a successful audit
Liz Allanson, ExPharmaceutical Inspectors Consortium

In-line technology
John Churchill, Cell and Gene Therapy Catapult

Register for manufacturing workshop

CGT Catapult Seminar Day at the University of Edinburgh
Are you based in Scotland or north east of England and involved in cell and gene therapy research, development or manufacturing? Want to learn how we can accelerate your advanced therapy research towards the clinic? We are at the University of Edinburgh MRC Centre for Regenerative Medicine on Monday 18 March to meet advanced therapy researchers and answer your questions!

View the agenda and RSVP below.

+44 (0) 203 728 9500
12th Floor Tower Wing, Guy’s Hospital, Great Maze Pond, London SE1 9RT

The Cell and Gene Therapy Catapult takes your data very seriously, you can read how we may use it in our privacy policy. If you no longer want to hear from us unsubscribe here.